These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 1875509
21. [Long-term experiences with autoinjection therapy of papaverine in erectile dysfunction]. Jantos C, Krause W, Kauss E, Weidner W. Urologe A; 1988 Jan; 27(1):18-21. PubMed ID: 3363769 [Abstract] [Full Text] [Related]
22. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. Levine SB, Althof SE, Turner LA, Risen CB, Bodner DR, Kursh ED, Resnick MI. J Urol; 1989 Jan; 141(1):54-7. PubMed ID: 2908954 [Abstract] [Full Text] [Related]
23. Papaverine-induced fibrosis of the corpus cavernosum. Fuchs ME, Brawer MK. J Urol; 1989 Jan; 141(1):125. PubMed ID: 2908935 [Abstract] [Full Text] [Related]
24. Intracorporeal calcifications after self-injection of papaverine. Pery M, Rosenberger A, Kaftori JK, Vardi Y. Radiology; 1990 Jul; 176(1):81-3. PubMed ID: 2191374 [Abstract] [Full Text] [Related]
26. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H. Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363 [Abstract] [Full Text] [Related]
27. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection. Hu KN, Burks C, Christy WC. J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714 [Abstract] [Full Text] [Related]
28. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. Bardin ED, Krieger JN. Int Urol Nephrol; 1990 Aug; 22(2):147-52. PubMed ID: 2354895 [Abstract] [Full Text] [Related]
29. Intracavernous self-injection of papaverine and verapamil: a clinical experience. Bolayir K, Gökşin N. Acta Chir Hung; 1994 Aug; 34(3-4):253-6. PubMed ID: 7618376 [Abstract] [Full Text] [Related]
30. Intracavernous injection therapy in post-priapism cavernosal fibrosis. Lakin MM, Montague DK. J Urol; 1988 Oct; 140(4):828-9. PubMed ID: 3418813 [Abstract] [Full Text] [Related]
31. Pharmacological erection: diagnosis and treatment applications in 69 patients. Nellans RE, Ellis LR, Kramer-Levien D. J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712 [Abstract] [Full Text] [Related]
32. Ultrasound imaging of the corpora cavernosa after priapism. Hamm B, Friedrich M, Kelâmi A. Eur Urol; 1985 Jul; 11(3):210-1. PubMed ID: 3896817 [No Abstract] [Full Text] [Related]
37. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. Shamloul R, Atteya A, Elnashaar A, Gadallah A, Zohdy W, Abdelsalam W. J Sex Med; 2005 Jan; 2(1):117-20. PubMed ID: 16422914 [Abstract] [Full Text] [Related]
38. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Hübler J, Szántó A, Könyves K. Int Urol Nephrol; 2003 Jan; 35(4):519-21. PubMed ID: 15198160 [Abstract] [Full Text] [Related]
39. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic. Armstrong DK, Convery A, Dinsmore WW. Int J STD AIDS; 1993 Jan; 4(4):214-6. PubMed ID: 8399501 [Abstract] [Full Text] [Related]